Benjamin F. Edwards & Company’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$7.61M Buy
55,775
+7,602
+16% +$1.06M 0.13% 171
2024
Q1
$7.38M Buy
48,173
+1,004
+2% +$150K 0.13% 170
2023
Q4
$6.72M Buy
47,169
+32,017
+211% +$4.27M 0.13% 173
2023
Q3
$1.99M Sell
15,152
-8,907
-37% -$1.35M 0.08% 247
2023
Q2
$3.83M Buy
24,059
+14,635
+155% +$2.36M 0.15% 143
2023
Q1
$1.49M Sell
9,424
-83
-0.9% -$12.4K 0.06% 267
2022
Q4
$1.33M Buy
9,507
+121
+1% +$17.2K 0.06% 288
2022
Q3
$1.21M Buy
9,386
+58
+0.6% +$8.37K 0.06% 283
2022
Q2
$1.31M Sell
9,328
-308
-3% -$44K 0.06% 278
2022
Q1
$1.34M Buy
9,636
+256
+3% +$39.2K 0.06% 295
2021
Q4
$1.64M Buy
9,380
+188
+2% +$31.3K 0.07% 262
2021
Q3
$1.52M Buy
9,192
+199
+2% +$34.3K 0.08% 249
2021
Q2
$1.62M Sell
8,993
-351
-4% -$64.1K 0.08% 251
2021
Q1
$1.8M Sell
9,344
-151
-2% -$29.1K 0.1% 223
2020
Q4
$1.92M Sell
9,495
-1,028
-10% -$213K 0.11% 195
2020
Q3
$2.21M Sell
10,523
-47
-0.4% -$10.5K 0.15% 160
2020
Q2
$2.32M Sell
10,570
-6,951
-40% -$1.39M 0.17% 141
2020
Q1
$3.04M Buy
17,521
+1,516
+9% +$250K 0.26% 96
2019
Q4
$2.46M Sell
16,005
-298
-2% -$44.5K 0.17% 146
2019
Q3
$2.48M Buy
16,303
+2,249
+16% +$356K 0.19% 130
2019
Q2
$2.15M Buy
14,054
+59
+0.4% +$9.01K 0.18% 140
2019
Q1
$2.25M Sell
13,995
-119
-0.8% -$18.5K 0.2% 122
2018
Q4
$2.18M Buy
14,114
+239
+2% +$37.2K 0.23% 106
2018
Q3
$2.09M Sell
13,875
-71
-0.5% -$10.1K 0.2% 121
2018
Q2
$1.89M Buy
13,946
+509
+4% +$62.8K 0.19% 127
2018
Q1
$1.79M Buy
13,437
+355
+3% +$47.7K 0.18% 127
2017
Q4
$1.95M Buy
13,082
+1,784
+16% +$243K 0.2% 120
2017
Q3
$1.49M Buy
11,298
+1,246
+12% +$167K 0.18% 127
2017
Q2
$1.34M Sell
10,052
-477
-5% -$64.4K 0.17% 126
2017
Q1
$1.42M Buy
10,529
+516
+5% +$66.8K 0.21% 108
2016
Q4
$1.2M Buy
10,013
+4,171
+71% +$492K 0.2% 125
2016
Q3
$731K Buy
5,842
+171
+3% +$22.4K 0.13% 172
2016
Q2
$785K Sell
5,671
-394
-6% -$51.1K 0.15% 149
2016
Q1
$765K Sell
6,065
-331
-5% -$42.1K 0.16% 140
2015
Q4
$811K Sell
6,396
-12
-0.2% -$1.49K 0.18% 132
2015
Q3
$740K Buy
6,408
+740
+13% +$83.1K 0.16% 139
2015
Q2
$590K Buy
5,668
+413
+8% +$44.6K 0.12% 183
2015
Q1
$580K Buy
5,255
+944
+22% +$102K 0.12% 172
2014
Q4
$449K Buy
4,311
+428
+11% +$42.8K 0.1% 189
2014
Q3
$373K Buy
3,883
+992
+34% +$89.7K 0.09% 215
2014
Q2
$264K Buy
2,891
+74
+3% +$6.63K 0.07% 259
2014
Q1
$248K Sell
2,817
-339
-11% -$29.8K 0.07% 252
2013
Q4
$293K Sell
3,156
-73
-2% -$6.58K 0.1% 198
2013
Q3
$264K Buy
3,229
+373
+13% +$31.5K 0.1% 192
2013
Q2
$237K Buy
+2,856
New +$246K 0.1% 191

Other funds holding CLX

Benjamin F. Edwards & Company's CLX Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Clorox (CLX) stake by 16% in Q2 2024, buying an estimated $1.06M and bringing the position to 55,775 shares worth $7.61M. The position accounts for 0.13% of the portfolio, ranked #171.

Benjamin F. Edwards & Company first reported a position in CLX in Q2 2013 and has held it in 45 quarters since. 1,092 funds tracked by Wall St. Rank hold CLX as of Q2 2024.

  • Benjamin F. Edwards & Company held 55,775 shares of Clorox worth $7.61M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 7,602 Clorox shares in Q2 2024, an estimated $1.06M.
  • Clorox made up 0.13% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #171 holding.
  • Benjamin F. Edwards & Company first reported a position in Clorox in Q2 2013 and has held it in 45 quarters since.
  • 1,092 funds tracked by Wall St. Rank held Clorox as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.